COVID-19 vaccine from AstraZeneca-Oxford slightly less effective than first touted: 76% rather than 79% against disease, updated data shows
AstraZeneca released updated information on its COVID-19 clinical trial Wednesday evening, showing an effectiveness rate of 76% instead of the ...